CLINICAL CHARACTERISTICS OF CHILDREN WITH COVID-19
Abstract
Covid-19 is a disease caused by the SARS-CoV-2 virus, which was registered in December 2019 in China. In February 2020, the World Health Organization declared the SARS-CoV-2 pandemic. The first pediatric patient in Serbia with covid-19 was registered on March 23, 2020, in the 13th week since the start of the pandemic. This disease, three years after the appearance of the first cases, continues to be a global public health challenge. Children get sick with covid-19 less often than adults. They are mostly infected by droplets in the household from family members, and they have a milder clinical picture and a better prognosis of the disease. The most common symptoms and signs of covid-19 in children are fever, cough, tachycardia and malaise. In the first waves of the pandemic, pneumonia had about a quarter to a third of the patients. The indiscriminate use of antibiotics in the treatment of sick children was one of the main problems during the pandemic. Considering that the covid-19 infection was a threat of global proportions, in addition to the impact on the health condition, the deterioration of the quality of life of children was also registered.
References
1. Sachs JD, Karim SSA, Aknin L, Allen J, Brosbol K, Colombo F, et al. The Lancet Commission on lessons for the future from the COVID-19 pandemic. Lancet. 2022 Oct 8;400(10359):1224-80.
2. Bialek S, Boundy E, Bowen V, Chow N, Cohn A, Dowling N, et al. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-6.
3. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. JAMA. 2020 Apr 14;323(14):1335.
4. Yoon Y, Kim KR, Park H, Kim S, Kim YJ. Stepwise School Opening and an Impact on the Epidemiology of COVID-19 in the Children. J Korean Med Sci. 2020 Nov 30;35(46):e414.
5. Paunic M, Filipovic S, Nieuwenhuis M, Obradovic M, Gazibara T. The dynamics of the COVID-19 epidemic among students at the University of Belgrade (Serbia), June 2020-March 2022. Epidemiol Prev. 2022;46(4):278-80.
6. Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020 Jun;215:108427.
7. Jeyanathan M, Afkhami S, Smaill F, Miller MS, Lichty BD, Xing Z. Immunological considerations for COVID-19 vaccine strategies. Nat Rev Immunol. 2020 Oct;20(10):615-32.
8. Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 Mar 13;367(6483):1260-3.
9. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020 Jun;109(6):1088-95.
10. Connors TJ, Ravindranath TM, Bickham KL, Gordon CL, Zhang F, Levin B, et al. Airway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection. Am J Respir Cell Mol Biol. 2016 Jun;54(6):822-30.
11. Nickbakhsh S, Mair C, Matthews L, Reeve R, Johnson PCD, Thorburn F, et al. Virus-virus interactions impact the population dynamics of influenza and the common cold. Proc Natl Acad Sci U S A. 2019 Dec 26;116(52):27142-50.
12. Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and Clinical Characteristics of COVID-19. Arch Iran Med. 2020 Apr 1;23(4):268-71.
13. Zimmermann P, Curtis N. Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children. Pediatr Infect Dis J. 2020 May;39(5):355-68.
14. Moazzam Z, Salim A, Ashraf A, Jehan F, Arshad M. Intussusception in an infant as a manifestation of COVID-19. J Pediatr Surg Case Rep. 2020 Aug;59:101533.
15. Landete P, Quezada Loaiza CA, Aldave-Orzaiz B, Muniz SH, Maldonado A, Zamora E, et al. Clinical features and radiological manifestations of COVID-19 disease. World J Radiol. 2020 Nov 28;12(11):247-60.
16. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020 Jun;145(6).
17. de Souza TH, Nadal JA, Nogueira RJN, Pereira RM, Brandao MB. Clinical manifestations of children with COVID-19: A systematic review. Pediatr Pulmonol. 2020 Aug;55(8):1892-9.
18. Dhochak N, Singhal T, Kabra SK, Lodha R. Pathophysiology of COVID-19: Why Children Fare Better than Adults? Indian J Pediatr. 2020 Jul;87(7):537-46.
19. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg. 2020 Sep;61(3):E304-E12.
20. Bhuiyan MU, Stiboy E, Hassan MZ, Chan M, Islam MS, Haider N, et al. Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis. Vaccine. 2021 Jan 22;39(4):667-77.
21. Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr;57(4):106324.
22. Sotoodeh Ghorbani S, Taherpour N, Bayat S, Ghajari H, Mohseni P, Hashemi Nazari SS. Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID-19: A systematic review and meta-analysis. J Med Virol. 2022 Jan;94(1):44-53.
23. Schwartz RA, Suskind RM. Azithromycin and COVID-19: Prompt early use at first signs of this infection in adults and children, an approach worthy of consideration. Dermatol Ther. 2020 Jul;33(4):e13785.
24. Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi H. Laboratory findings in COVID-19 diagnosis and prognosis. Clin Chim Acta. 2020 Nov;510:475-82.
25. Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A. Characteristics and Outcomes of Coronavirus Infection in Children: The Role of Viral Factors and an Immunocompromised State. J Pediatric Infect Dis Soc. 2019 Mar 28;8(1):21-8.
26. Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA, Jr., Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020 Aug;146(2):327-9 e4.
27. Prijic A, Gazibara T, Nikolic D, Ostojic O, Maksimovic N. Critically Severe COVID-19 in a Child with Residual Motor Deficit Due to Guillain-Barre Syndrome. Klin Padiatr. 2022 Mar;234(2):123-6.
28. Schoeman D, Fielding BC. Coronavirus envelope protein: current knowledge. Virol J. 2019 May 27;16(1):69.
29. Zheng F, Liao C, Fan QH, Chen HB, Zhao XG, Xie ZG, et al. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci. 2020 Apr;40(2):275-80.
30. WHO. Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases. Interim guidance. 2020; Available from: https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117.
31. Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021 Oct;5(10):708-18.
32. Henry BM, Benoit SW, de Oliveira MHS, Hsieh WC, Benoit J, Ballout RA, et al. Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review. Clin Biochem. 2020 Jul;81:1-8.
33. Jiehao C, Jin X, Daojiong L, Zhi Y, Lei X, Zhenghai Q, et al. A Case Series of Children With 2019 Novel Coronavirus Infection: Clinical and Epidemiological Features. Clin Infect Dis. 2020 Sep 12;71(6):1547-51.
34. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May;109:102433.
35. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004 Jul;191(1):292-7.
36. Stogiannos N, Fotopoulos D, Woznitza N, Malamateniou C. COVID-19 in the radiology department: What radiographers need to know. Radiography (Lond). 2020 Aug;26(3):254-63.
37. Ilundain Lopez de Munain A, Jimenez Veintemilla C, Herranz Aguirre M, Viguria Sanchez N, Ramos-Lacuey B, Urretavizcaya-Martinez M, et al. Chest radiograph in hospitalized children with COVID-19. A review of findings and indications. Eur J Radiol Open. 2021;8:100337.
38. Biko DM, Ramirez-Suarez KI, Barrera CA, Banerjee A, Matsubara D, Kaplan SL, et al. Imaging of children with COVID-19: experience from a tertiary children's hospital in the United States. Pediatr Radiol. 2021 Feb;51(2):239-47.
39. Kumar J, Meena J, Yadav A, Yadav J. Radiological Findings of COVID-19 in Children: A Systematic Review and Meta-Analysis. J Trop Pediatr. 2021 Jul 2;67(3).
40. Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, et al. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19. Radiology. 2020 Aug;296(2):E72-E8.
41. Lomoro P, Verde F, Zerboni F, Simonetti I, Borghi C, Fachinetti C, et al. COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review. Eur J Radiol Open. 2020;7:100231.
42. Mussini C, Cozzi-Lepri A. Another piece in the COVID-19 treatment puzzle. Lancet. 2022 Feb 12;399(10325):609-10.
43. World-Health-Organization. Therapeutics and COVID-19 Living Guide. 2022; Available from: https://apps.who.int/iris/bitstream/handle/10665/345356/WHO-2019-nCoV-therapeutics-2021.3-eng.pdf
44. Popp M, Stegemann M, Riemer M, Metzendorf MI, Romero CS, Mikolajewska A, et al. Antibiotics for the treatment of COVID-19. Cochrane Database Syst Rev. 2021 Oct 22;10(10):CD015025.
45. Lucien MAB, Canarie MF, Kilgore PE, Jean-Denis G, Fenelon N, Pierre M, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings. Int J Infect Dis. 2021 Mar;104:250-4.
46. Chitungo I, Dzinamarira T, Nyazika TK, Herrera H, Musuka G, Murewanhema G. Inappropriate Antibiotic Use in Zimbabwe in the COVID-19 Era: A Perfect Recipe for Antimicrobial Resistance. Antibiotics (Basel). 2022 Feb 13;11(2).
47. Giacomelli A, Ridolfo AL, Oreni L, Vimercati S, Albrecht M, Cattaneo D, et al. Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate? Pharmacol Res. 2021 Feb;164:105403.
48. Abelenda-Alonso G, Padulles A, Rombauts A, Gudiol C, Pujol M, Alvarez-Pouso C, et al. Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern. Infect Control Hosp Epidemiol. 2020 Nov;41(11):1371-2.
49. Silva ARO, Salgado DR, Lopes LPN, Castanheira D, Emmerick ICM, Lima EC. Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital. Front Pharmacol. 2021;12:778386.
50. Pierce J, Stevens MP. COVID-19 and antimicrobial stewardship: lessons learned, best practices, and future implications. Int J Infect Dis. 2021 Dec;113:103-8.
51. National-Institutes-of-Health. Therapeutic Management of Hospitalized Children with COVID-19. 2022; Available from: https://www.covid19treatmentguidelines.nih.gov/management/clinical-management-of-children/hospitalized-childrentherapeutic-management.
52. Delorme C, Viel-Theriault I, Moradipour T, Le Saux N. Drug use evaluation (DUE) of ceftriaxone: A quality metric in a pediatric hospital. J Assoc Med Microbiol Infect Dis Can. 2020 Oct;5(3):139-44.
53. Ghosh S, Bornman C, Zafer MM. Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand? J Infect Public Health. 2021 May;14(5):555-60.
54. Prijic A, Gazibara T, Prijic S, Mandic-Rajcevic S, Maksimovic N. Factors Associated with the Antibiotic Treatment of Children Hospitalized for COVID-19 during the Lockdown in Serbia. Int J Environ Res Public Health. 2022 Nov 24;19(23).
55. Capalbo C, Aceti A, Simmaco M, Bonfini R, Rocco M, Ricci A, et al. The Exponential Phase of the Covid-19 Pandemic in Central Italy: An Integrated Care Pathway. Int J Environ Res Public Health. 2020 May 27;17(11).
56. Wang J, Tang Y, Ma Y, Zhou Q, Li W, Baskota M, et al. Efficacy and safety of antibiotic agents in children with COVID-19: a rapid review. Ann Transl Med. 2020 May;8(10):619.
57. Allen H, Vusirikala A, Flannagan J, Twohig KA, Zaidi A, Chudasama D, et al. Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study. Lancet Reg Health Eur. 2022 Jan;12:100252.
58. Venturini E, Montagnani C, Garazzino S, Dona D, Pierantoni L, Lo Vecchio A, et al. Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease. Ital J Pediatr. 2020 Sep 24;46(1):139.
59. Kepenekli E, Yakut N, Ergenc Z, Aydiner O, Sarinoglu RC, Karahasan A, et al. COVID-19 disease characteristics in different pediatric age groups. J Infect Dev Ctries. 2022 Jan 31;16(1):16-24.
60. Langford BJ, So M, Raybardhan S, Leung V, Soucy JR, Westwood D, et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clin Microbiol Infect. 2021 Apr;27(4):520-31.
61. Kalam A, Shano S, Khan MA, Islam A, Warren N, Hassan MM, et al. Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance. PLoS One. 2021;16(12):e0261368.